Edward Keith Russell's most recent trade in QuidelOrtho Corporation was a trade of 4,606 Common Stock done . Disclosure was reported to the exchange on Jan. 16, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2022 | 4,606 | 30,732 (0%) | 0% | 0 | Common Stock | |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2022 | 4,606 | 0 | - | - | Restricted Stock Units | |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 114.88 per share. | 16 Jan 2022 | 1,662 | 29,070 (0%) | 0% | 114.9 | 190,931 | Common Stock |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 4,606 | 26,584 (0%) | 0% | 0 | Common Stock | |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 3,623 | 27,923 (0%) | 0% | 0 | Common Stock | |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.10 per share. | 18 Feb 2021 | 2,284 | 24,300 (0%) | 0% | 210.1 | 479,868 | Common Stock |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.10 per share. | 18 Feb 2021 | 1,797 | 26,126 (0%) | 0% | 210.1 | 377,550 | Common Stock |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2021 | 7,172 | 0 | - | - | Restricted Stock Units | |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 7,172 | 25,448 (0%) | 0% | 0 | Common Stock | |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.97 per share. | 15 Feb 2021 | 3,470 | 21,978 (0%) | 0% | 228.0 | 791,056 | Common Stock |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 1,661 | 4,980 | - | - | Restricted Stock Units | |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 1,661 | 18,851 (0%) | 0% | 0 | Common Stock | |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 236.85 per share. | 03 Feb 2021 | 575 | 18,276 (0%) | 0% | 236.9 | 136,189 | Common Stock |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 1,893 | 1,893 | - | - | Restricted Stock Units | |
QuidelOrtho Corporation | Edward Keith Russell | SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 1,892 | 1,892 | - | - | Non-Qualified Stock Option |